Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Abstract Acamprosate is a gamma-aminobutyric acid (GABA) analogue for which evidence is accumulating of a clinically useful benefit when used as an adjunct for conventional treatments to prevent relapse in alcohol dependence. This paper reviews published randomized controlled studies involving 1304 patients. To date no abstinence syndrome associated with acamprosate has been identified nor serious adverse effects. It is not effective in all patients, and the characteristics of the individuals most likely to respond and the treatment setting and modalities in which it is likely to be most helpful, have yet to be specified. This content is only available as a PDF. © 1995 Medical Council on Alcoholism
Alcohol and Alcoholism – Oxford University Press
Published: Nov 1, 1995
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.